AXA SA

ENXTPA:CS Voorraadrapport

Marktkapitalisatie: €83.0b

AXA Toekomstige groei

Future criteriumcontroles 2/6

AXA zal naar verwachting groeien in winst en omzet met respectievelijk 6.7% en 7.5% per jaar. De winst per aandeel zal naar verwachting groeien met 8.5% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 18.2% zijn.

Belangrijke informatie

6.7%

Groei van de winst

8.54%

Groei van de winst per aandeel

Insurance winstgroei5.6%
Inkomstengroei7.5%
Toekomstig rendement op eigen vermogen18.19%
Dekking van analisten

Good

Laatst bijgewerkt15 May 2026

Recente toekomstige groei-updates

Recent updates

Narratiefupdate • May 08

CS: Technical And Fee-Based Shift Plus Buybacks Will Support Measured Re-Rating

AXA's fair value estimate edges higher to €46.12 from €46.07 as analysts refine assumptions around revenue growth, profit margins and future P/E, supported by a series of recent price target increases and bullish initiations on the stock. Analyst Commentary Recent Street research around AXA has been active, with several price target revisions and fresh initiations feeding into the updated fair value estimate.
Narratiefupdate • Apr 22

CS: Technical And Fee-Based Earnings Mix Will Support Re-Rating As Discount Persists

Analysts have nudged their average price target for AXA slightly higher to about €46.07. This reflects modest tweaks to assumptions around discount rates, profit margins and future P/E multiples, alongside recent Street research that includes both upward and downward target revisions clustered around the €46 to €50 range.
Narratiefupdate • Apr 07

CS: Technical And Fee-Based Earnings Shift Will Support Re-Rating As Discount Persists

AXA's analyst price targets have edged higher into a €46 to €50.70 range, as analysts point to improved profitability from technical insurance and fee-based earnings, along with what they view as an ongoing discount to European composite peers. Analyst Commentary Recent research points to a cluster of higher price targets for AXA, with analysts largely focused on the mix of technical insurance and fee-based earnings and how that feeds into profitability, earnings stability, and valuation relative to European peers.
Narratiefupdate • Mar 24

CS: Technical And Fee-Based Shift Will Support Re-Rating As Discount Persists

Analysts have nudged AXA's average price target higher to around €48 to €51, citing improved profitability from its focus on technical insurance and fee-based earnings and pointing out that the current valuation still sits at a discount to European composite peers. Analyst Commentary Recent Street research has tilted positive on AXA, with several banks lifting their price targets into a relatively tight band between €46 and about €51.
Narratiefupdate • Mar 10

CS: Technical And Fee-Based Shift Will Support Re-Rating Versus European Composite Peers

Our AXA fair value estimate has been adjusted from €45.27 to €46.05. This reflects higher analyst price targets in the €46 to €50.70 range and their focus on improved profitability, lower earnings volatility and a reduced P/E assumption.
Narratiefupdate • Feb 23

CS: Technical And Fee-Based Shift Will Support Higher Future Earnings Multiple

Analysts have nudged their price target for AXA slightly higher to about €45.27 from roughly €45.11, citing continued focus on technical insurance and fee-based earnings that they say is supporting improved profitability and a higher assumed future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts point to the shift towards technical insurance and fee-based earnings as a key support for more stable and higher quality profit streams, which they see as supportive of a stronger P/E multiple over time.
Narratiefupdate • Feb 08

CS: Slightly Lower Discount Rate Will Support Forward Earnings Appeal

The analyst fair value estimate for AXA has been adjusted slightly higher to €45.11 from €45.06, as analysts refine their assumptions around discount rates, revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value Estimate adjusted slightly higher to €45.11 from €45.06.
Narratiefupdate • Jan 24

CS: Stable Assumptions And Slightly Higher Required Return Will Support Forward Earnings Appeal

Analysts have slightly raised their fair value estimate for AXA to €45.06 from €44.98, citing adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a marginally higher price target. Valuation Changes Fair value estimate is now set at €45.06, up slightly from €44.98, reflecting a very small adjustment in the model.
Narratiefupdate • Jan 10

CS: Stable Assumptions And Slightly Lower P/E Will Support Forward Earnings Appeal

Analysts have reduced their price target for AXA slightly to about €45, reflecting small adjustments to fair value estimates, discount rate assumptions and future P/E expectations, while keeping revenue growth and profit margin forecasts broadly unchanged. Valuation Changes Fair Value: Adjusted slightly from €45.07 to €44.98, indicating a very small reduction in the estimated fair value per share.
Narratiefupdate • Dec 17

CS: Lower Discount Rate Will Support Stronger Forward Earnings Appeal

Analysts have nudged their price target on AXA slightly higher to approximately €45.07 from about €45.04, citing a marginally lower discount rate and modest improvements in projected profit margins that together support a slightly richer valuation multiple. Valuation Changes Fair Value has risen slightly from approximately €45.04 to about €45.07, reflecting a marginal uplift in the intrinsic valuation estimate.
Narratiefupdate • Dec 03

CS: Modestly Higher Future Multiple Will Support Attractive Upside Potential

Analysts have modestly raised their price target on AXA to €45.04, citing a slightly higher assumed future price to earnings multiple, which more than offsets marginal adjustments to the discount rate and profit margin forecasts. Valuation Changes Fair Value Estimate unchanged at approximately €45.04 per share, indicating no revision to the intrinsic value assessment.
Narratiefupdate • Nov 19

CS: Strong Profit Margins And Stable P/E Will Drive Future Gains

Analysts have slightly raised their price target for AXA, increasing it from €44.96 to €45.04. This change is based on modest adjustments to projected revenue growth, profit margins, and discount rates.
Narratiefupdate • Nov 02

CS: Rising Profit Margins And Multiples Will Drive Global Expansion

Analysts have slightly raised their price target for AXA from €44.58 to €44.96, citing incremental improvements in profit margin and expected future earnings multiples as key factors supporting the revision. Valuation Changes Fair Value has increased slightly from €44.58 to €44.96.
Analyseartikel • Aug 05

These Analysts Think AXA SA's (EPA:CS) Sales Are Under Threat

ENXTPA:CS 1 Year Share Price vs Fair Value Explore AXA's Fair Values from the Community and select yours One thing we...
Analyseartikel • Jul 04

Here's Why AXA (EPA:CS) Has Caught The Eye Of Investors

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
User avatar
Nieuw narratief • Nov 07

Calculated Market Expansion And Innovative Products Drive Revenue Growth And Profitability

AXA's disciplined pricing and focus on operational excellence aim to enhance profitability in international markets.

Winst- en omzetgroeiprognoses

ENXTPA:CS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2028120,9989,4158,9006,5403
12/31/2027119,0438,9347,2286,4614
12/31/2026111,1288,4916,8596,4273
12/31/202594,6917,27422,24222,670N/A
9/30/202593,9517,20321,37321,822N/A
6/30/202593,2117,13220,50320,974N/A
3/31/202592,2337,13115,95316,426N/A
12/31/202491,2557,13011,40211,878N/A
9/30/202486,1837,431N/AN/AN/A
6/30/202488,5706,6405,9276,392N/A
3/31/202487,1446,6544,7505,192N/A
12/31/202385,7176,6673,5733,992N/A
9/30/202386,1925,9327,2507,673N/A
6/30/202385,2334,8599,1619,580N/A
3/31/202386,0134,8698,7349,143N/A
12/31/202286,7934,8798,3078,705N/A
9/30/202295,6915,9205,3835,737N/A
6/30/2022104,5886,9612,4592,769N/A
3/31/2022113,3807,0314,3184,648N/A
12/31/2021122,1717,1006,1766,526N/A
9/30/2021121,9056,32411,48411,872N/A
6/30/2021121,6395,54816,79217,217N/A
3/31/2021116,9934,26820,96921,376N/A
12/31/2020112,3472,98725,14525,534N/A
6/30/2020110,2322,76919,74220,137N/A
3/31/2020121,6713,19814,05414,482N/A
12/31/2019133,1093,6278,3658,827N/A
6/30/2019124,0371,822N/A5,029N/A
3/31/2019115,2312,064N/A6,332N/A
12/31/2018106,4252,306N/A7,634N/A
9/30/2018114,7093,694N/A9,704N/A
6/30/2018123,0105,509N/A11,773N/A
3/31/2018127,8015,745N/A14,149N/A
12/31/2017132,5925,980N/A16,525N/A
9/30/2017131,8615,831N/AN/AN/A
6/30/2017131,1295,682N/A15,904N/A
3/31/2017129,0805,842N/A14,722N/A
12/31/2016127,0316,001N/A13,539N/A
9/30/2016120,9085,912N/AN/AN/A
6/30/2016114,7845,823N/A16,396N/A
3/31/2016115,1215,536N/A17,311N/A
12/31/2015115,4585,248N/A18,226N/A
9/30/2015119,6565,001N/AN/AN/A
6/30/2015123,8534,753N/A17,201N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei CS ( 6.7% per jaar) ligt boven de spaarquote ( 2.5% ).

Winst versus markt: De winst van CS ( 6.7% per jaar) zal naar verwachting langzamer groeien dan de markt French ( 12.4% per jaar).

Hoge groeiwinsten: De winst van CS zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van CS ( 7.5% per jaar) zal naar verwachting sneller groeien dan de markt French ( 5.6% per jaar).

Hoge groei-inkomsten: De omzet van CS ( 7.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen CS zal naar verwachting over 3 jaar laag zijn ( 18.2 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/20 02:46
Aandelenkoers aan het einde van de dag2026/05/20 00:00
Inkomsten2025/12/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

AXA SA wordt gevolgd door 35 analisten. 12 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Markus MayerBaader Helvea Equity Research
null nullBanco de Sabadell. S.A.
Valvanera Gómez PastorBanco Santander